JP2024505790A5 - - Google Patents

Info

Publication number
JP2024505790A5
JP2024505790A5 JP2023536875A JP2023536875A JP2024505790A5 JP 2024505790 A5 JP2024505790 A5 JP 2024505790A5 JP 2023536875 A JP2023536875 A JP 2023536875A JP 2023536875 A JP2023536875 A JP 2023536875A JP 2024505790 A5 JP2024505790 A5 JP 2024505790A5
Authority
JP
Japan
Prior art keywords
sequence
pharmaceutical composition
antibody
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/061926 external-priority patent/WO2022130318A2/en
Publication of JP2024505790A publication Critical patent/JP2024505790A/ja
Publication of JP2024505790A5 publication Critical patent/JP2024505790A5/ja
Pending legal-status Critical Current

Links

JP2023536875A 2020-12-18 2021-12-17 インテグリンアルファ11ベータ1に対する抗体 Pending JP2024505790A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063127849P 2020-12-18 2020-12-18
US63/127,849 2020-12-18
US202163213973P 2021-06-23 2021-06-23
US63/213,973 2021-06-23
PCT/IB2021/061926 WO2022130318A2 (en) 2020-12-18 2021-12-17 Antibodies against integrin alpha 11 beta 1

Publications (2)

Publication Number Publication Date
JP2024505790A JP2024505790A (ja) 2024-02-08
JP2024505790A5 true JP2024505790A5 (cg-RX-API-DMAC7.html) 2024-12-25

Family

ID=79021748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536875A Pending JP2024505790A (ja) 2020-12-18 2021-12-17 インテグリンアルファ11ベータ1に対する抗体

Country Status (13)

Country Link
US (1) US20240317865A1 (cg-RX-API-DMAC7.html)
EP (1) EP4263605A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024505790A (cg-RX-API-DMAC7.html)
KR (1) KR20230121831A (cg-RX-API-DMAC7.html)
AU (1) AU2021400221A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023011777A2 (cg-RX-API-DMAC7.html)
CA (1) CA3205574A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023001757A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023008544A2 (cg-RX-API-DMAC7.html)
IL (1) IL303741A (cg-RX-API-DMAC7.html)
MX (1) MX2023007302A (cg-RX-API-DMAC7.html)
TW (1) TW202241946A (cg-RX-API-DMAC7.html)
WO (1) WO2022130318A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12022551471A1 (en) 2019-12-20 2023-04-24 Momenta Pharmaceuticals Inc Antibodies against integrin alpha 11 beta 1

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3681787D1 (de) 1985-07-05 1991-11-07 Whitehead Biomedical Inst Expression von fremdem genetischem material in epithelzellen.
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
HK1008049A1 (en) 1987-09-11 1999-04-30 Whitehead Institute For Biomedical Research Transduced fibroblasts and use therefor
ATE110108T1 (de) 1987-12-11 1994-09-15 Whitehead Biomedical Inst Genetische modifizierung von endothelialen zellen.
DE68927996T2 (de) 1988-02-05 1997-12-04 Hughes Howard Med Inst Modifizierte hepatozyten und deren anwendung
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DE69123981T3 (de) 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie
SE9201984D0 (sv) 1992-06-29 1992-06-29 Pharmacia Biosensor Ab Improvement in optical assays
US5308341A (en) 1993-09-28 1994-05-03 Becton, Dickinson And Company Method of testing the dose accuracy of a medication delivery device
US6146361A (en) 1996-09-26 2000-11-14 Becton Dickinson And Company Medication delivery pen having a 31 gauge needle
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
US6192891B1 (en) 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
US6277099B1 (en) 1999-08-06 2001-08-21 Becton, Dickinson And Company Medication delivery pen
JP4383168B2 (ja) 2001-09-12 2009-12-16 ベクトン・ディキンソン・アンド・カンパニー マイクロ針投与デバイスおよび薬物投与デバイス
FR2849436B1 (fr) 2002-12-27 2007-01-05 Patrick Frayssinet Particules et ceramiques de phosphates de calcium pour transfection in vivo et in vitro
EP3524625A1 (en) * 2018-02-08 2019-08-14 Bergen Teknologioverforing AS Antibody against alpha-11 integrin and its use
US20230065153A1 (en) * 2018-03-01 2023-03-02 Hiroshima University Anti-integrin alpha-11 monoclonal antibody and use thereof
PH12022551471A1 (en) * 2019-12-20 2023-04-24 Momenta Pharmaceuticals Inc Antibodies against integrin alpha 11 beta 1

Similar Documents

Publication Publication Date Title
JP2006516409A5 (cg-RX-API-DMAC7.html)
RU2019118359A (ru) Антитело к cd73 человека
HRP20120376T1 (hr) Nova protutijela protiv il-13 i njihove upotrebe
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2020152735A5 (cg-RX-API-DMAC7.html)
CN112409488B (zh) 针对多种冠状病毒的单克隆抗体及应用
JP2022023051A (ja) 瘻孔を伴うクローン病の治療用ベドリズマブ
JP2019522961A5 (cg-RX-API-DMAC7.html)
JP2009537608A5 (cg-RX-API-DMAC7.html)
JP2018108081A5 (cg-RX-API-DMAC7.html)
CN106103479B (zh) 识别其它ccr3-结合趋化因子的抗嗜酸粒细胞趋化因子-2抗体
JP2022540083A5 (cg-RX-API-DMAC7.html)
HRP20170407T1 (hr) Anti-epha2 anitijelo
JP2010516229A5 (cg-RX-API-DMAC7.html)
JP2008521440A5 (cg-RX-API-DMAC7.html)
JP2012504955A5 (cg-RX-API-DMAC7.html)
JP2011528902A5 (cg-RX-API-DMAC7.html)
JP2026001077A5 (cg-RX-API-DMAC7.html)
JP2022538232A5 (cg-RX-API-DMAC7.html)
CN110483637B (zh) 一种抗禽流感病毒神经氨酸酶n2单克隆抗体、编码基因及其应用
JPWO2023026791A5 (cg-RX-API-DMAC7.html)
JP2020522535A5 (cg-RX-API-DMAC7.html)
JPWO2020059847A5 (cg-RX-API-DMAC7.html)
RU2008140947A (ru) Антитела к egfl7 и способы их применения
JP2022502024A5 (cg-RX-API-DMAC7.html)